Alexander Nowak
Stock Analyst at Craig-Hallum
(2.71)
# 1,869
Out of 5,149 analysts
46
Total ratings
45.95%
Success rate
7.08%
Average return
Main Sectors:
Stocks Rated by Alexander Nowak
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CELC Celcuity | Maintains: Buy | $96 → $108 | $107.40 | +0.56% | 3 | Nov 13, 2025 | |
| CVRX CVRx, Inc. | Maintains: Buy | $20 → $22 | $8.18 | +168.95% | 5 | Jan 17, 2025 | |
| NTRA Natera | Maintains: Buy | $121 → $157 | $207.04 | -24.17% | 4 | Nov 13, 2024 | |
| BVS Bioventus | Maintains: Buy | $12 → $17 | $8.74 | +94.51% | 6 | Sep 27, 2024 | |
| QDEL QuidelOrtho | Upgrades: Buy | $40 → $57 | $21.48 | +165.36% | 6 | Sep 5, 2024 | |
| CDNA CareDx | Upgrades: Buy | $12 → $15 | $18.80 | -20.21% | 3 | May 1, 2024 | |
| DMAC DiaMedica Therapeutics | Assumes: Buy | $8 | $7.71 | +3.76% | 4 | Apr 24, 2024 | |
| LUNG Pulmonx | Initiates: Buy | $18 | $1.53 | +1,076.47% | 1 | Sep 5, 2023 | |
| TNDM Tandem Diabetes Care | Maintains: Buy | $74 → $50 | $23.74 | +110.62% | 2 | Jun 13, 2023 | |
| DRIO DarioHealth | Maintains: Buy | $280 → $160 | $10.30 | +1,453.40% | 1 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $103.37 | - | 1 | Oct 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $0.81 | - | 2 | Mar 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $11 | $2.14 | +414.02% | 1 | Jan 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $88 → $110 | $56.99 | +93.02% | 3 | Feb 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | n/a | $6.83 | - | 2 | Jan 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $300 | $1.35 | +22,122.22% | 1 | Jan 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $28 | $9.18 | +205.01% | 1 | Aug 31, 2020 |
Celcuity
Nov 13, 2025
Maintains: Buy
Price Target: $96 → $108
Current: $107.40
Upside: +0.56%
CVRx, Inc.
Jan 17, 2025
Maintains: Buy
Price Target: $20 → $22
Current: $8.18
Upside: +168.95%
Natera
Nov 13, 2024
Maintains: Buy
Price Target: $121 → $157
Current: $207.04
Upside: -24.17%
Bioventus
Sep 27, 2024
Maintains: Buy
Price Target: $12 → $17
Current: $8.74
Upside: +94.51%
QuidelOrtho
Sep 5, 2024
Upgrades: Buy
Price Target: $40 → $57
Current: $21.48
Upside: +165.36%
CareDx
May 1, 2024
Upgrades: Buy
Price Target: $12 → $15
Current: $18.80
Upside: -20.21%
DiaMedica Therapeutics
Apr 24, 2024
Assumes: Buy
Price Target: $8
Current: $7.71
Upside: +3.76%
Pulmonx
Sep 5, 2023
Initiates: Buy
Price Target: $18
Current: $1.53
Upside: +1,076.47%
Tandem Diabetes Care
Jun 13, 2023
Maintains: Buy
Price Target: $74 → $50
Current: $23.74
Upside: +110.62%
DarioHealth
May 12, 2023
Maintains: Buy
Price Target: $280 → $160
Current: $10.30
Upside: +1,453.40%
Oct 19, 2022
Downgrades: Hold
Price Target: n/a
Current: $103.37
Upside: -
Mar 28, 2022
Downgrades: Hold
Price Target: n/a
Current: $0.81
Upside: -
Jan 5, 2022
Initiates: Buy
Price Target: $11
Current: $2.14
Upside: +414.02%
Feb 3, 2021
Maintains: Buy
Price Target: $88 → $110
Current: $56.99
Upside: +93.02%
Jan 20, 2021
Downgrades: Sell
Price Target: n/a
Current: $6.83
Upside: -
Jan 11, 2021
Initiates: Buy
Price Target: $300
Current: $1.35
Upside: +22,122.22%
Aug 31, 2020
Initiates: Buy
Price Target: $28
Current: $9.18
Upside: +205.01%